PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1955068
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1955068
The global poultry diagnostics market was valued at USD 1.05 billion in 2025 and is projected to grow from USD 1.13 billion in 2026 to USD 3.31 billion by 2034, registering a strong CAGR of 14.31% during the forecast period (2026-2034).
North America dominated the market with a 53.02% share in 2025, supported by advanced veterinary infrastructure and strong biosecurity initiatives.
Poultry diagnostic tests are essential for disease surveillance and effective control of infectious poultry diseases such as avian influenza, Newcastle disease, infectious bronchitis, colibacillosis, mycoplasmosis, infectious bursal disease, and avian reovirus. Rising disease outbreaks and increasing global demand for poultry-derived products are driving the need for early and accurate diagnostic solutions.
Market Dynamics
Market Drivers
The rising prevalence of poultry diseases is a primary driver of market growth. Frequent outbreaks of avian influenza and other viral infections significantly increase the need for surveillance and testing. Government authorities worldwide are strengthening biosecurity frameworks and investing in disease monitoring programs to safeguard food security and poultry exports.
Additionally, the increasing global consumption of poultry meat and eggs has heightened awareness among farmers regarding flock health management. Governments and non-government organizations are implementing training programs and funding initiatives to promote disease prevention and early diagnosis.
Growing research and development activities by leading players, strategic partnerships, and product launches are further accelerating market expansion.
Market Restraints
Despite rapid growth, lack of awareness and limited access to veterinary healthcare in emerging regions restrain market penetration. In several low-income countries, poultry farmers lack proper knowledge about diagnostic services and vaccination programs.
Limited laboratory infrastructure, inadequate trained professionals, and lower adoption of biosecurity measures also restrict the use of advanced diagnostic technologies in rural areas.
Market Opportunities
The growing adoption of point-of-care (POC) diagnostic solutions presents significant opportunities. Rapid diagnostic kits provide quick results, affordability, portability, and ease of use, especially in remote poultry farms.
Collaborations between diagnostic companies, veterinary institutions, and agricultural authorities are creating growth opportunities. Increasing government funding for poultry health and biosecurity programs will further support market expansion through 2034.
Market Trends
Growing Preference for Point-of-Care Diagnostics
One of the most prominent trends in the poultry diagnostics market is the increasing shift toward point-of-care testing (POCT). Traditional laboratory methods such as RT-PCR and ELISA require skilled professionals and extended processing time. In contrast, rapid diagnostic kits offer immediate results and are highly suitable for field use.
Emerging markets are increasingly adopting these portable solutions due to cost-effectiveness and improved disease control efficiency. This trend is expected to significantly influence market growth during the forecast period.
By Product
The market is divided into instruments and consumables & kits.
The consumables & kits segment dominated with 78.78% market share in 2026, driven by rising usage of rapid diagnostic kits. These kits are affordable, portable, and widely accessible across rural settings.
The instruments segment is expected to grow steadily due to increasing laboratory-based testing in developed regions.
By Technology
Based on technology, the market includes ELISA, PCR, immunofluorescent assay, hemagglutination assay, and others.
By Disease Indication
The market is categorized into avian influenza, infectious bursal disease, Newcastle disease, avian salmonellosis, mycoplasma, and others.
By End-User
The market includes veterinary diagnostic laboratories, veterinary hospitals & clinics, and others.
North America
North America led the market with USD 0.56 billion in 2025 and USD 0.60 billion in 2026. Strong government biosecurity investments and leading market players contribute to dominance.
Asia Pacific
Asia Pacific is projected to witness the highest CAGR through 2034, driven by expanding poultry farming and rising disease incidence. China, Japan, and India are key contributors.
Europe
Europe held a significant share due to strict animal welfare regulations and diagnostic advancements. Government initiatives to improve poultry health standards are supporting growth.
Latin America & Middle East & Africa
Latin America is expected to grow at the second-highest CAGR due to rising government funding. The Middle East & Africa region shows slower growth due to limited awareness and infrastructure gaps.
Competitive Landscape
Leading companies include IDEXX Laboratories, Inc., Zoetis Services LLC, Thermo Fisher Scientific Inc., GD, BioChek, BIONOTE, Vimian, and Innovative Diagnostics.
IDEXX Laboratories dominates the global market due to its strong product portfolio and global distribution network. Companies are focusing on strategic collaborations, new product launches, and expanding production capacity to strengthen market presence.
Conclusion
The global poultry diagnostics market is poised for significant growth, expanding from USD 1.05 billion in 2025 to USD 3.31 billion by 2034, at a robust CAGR of 14.31%. Rising disease outbreaks, increasing poultry consumption, and growing biosecurity initiatives are key growth drivers. While awareness gaps and infrastructure limitations pose challenges, the adoption of point-of-care diagnostics and strong government support will accelerate market expansion. North America will continue to dominate, while Asia Pacific is expected to emerge as the fastest-growing region during the forecast period.
Segmentation By Product
By Technology
By Disease Indication
By End-user
By Region